British media are reporting that vaccinations with the human papilloma virus vaccine Cervarix will resume immediately after an autopsy showed that 14-year-old Natalie Morton died from a serious ...

The FDA has approved Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant, from GlaxoSmithKline) for the prevention of cervical pre-cancers and cervical cancer associated ...

The Food and Drug Administration today approved Cervarix, the vaccine against human papilloma virus (HPV) manufactured by GlaxoSmithKline, for use in girls and young women ages 10 to 25.

GlaxoSmithKline PLC's Cervarix vaccine induced a higher immune response in women against the virus that causes cervical cancer than Merck & Co.'s Gardasil, according to a Glaxo-funded clinical ...

Cervarix: the simple injection causing so much controversy The cervical cancer jab Cervarix is currently under scrutiny after nearly 1,500 Britons have experienced adverse reactions to it.

And the Academy Award for Best Performance by a Vaccine in the Unbranded Category goes to… Cervarix! Forget Avatar vs. Hurt Locker, GlaxoSmithKline scored big on Oscar night with its own hit—an ...

British drug giant GlaxoSmithKline said Wednesday its cervical cancer vaccine candidate Cervarix has been recommended for approval in Europe.

LONDON (MarketWatch) -- Drug maker GlaxoSmithKline PLC GSK Monday said Cervarix, a cervical cancer vaccine expected to become a multibillion-dollar product, has been approved by health regulators ...

SAN FRANCISCO (MarketWatch) -- GlaxoSmithKline Plc GSK, -1.04% on Friday said mathematical data shows that its Cervarix vaccine candidate against types 16 and 18 of cervical cancer may prevent 80% ...

An extended follow-up study shows that Cervarix generates sustained high levels of neutralizing antibodies against human papillomavirus types 16 and 18 for up to 6.4 years.

GlaxoSmithKline launched its cervical cancer vaccine Cervarix in the UK on Tuesday, pricing it at about the same level as rival treatment, Merck’s Gardasil.

Separately, the FDA said Cervarix, a vaccine by GlaxoSmithKline PLC that would compete against Gardasil if approved, was effective at preventing a pre-cancerous condition that can lead cervical ...